Latest Balance Sheet News

Page 17 of 609
Far East Gold’s cash position has tightened sharply, with only A$593,000 remaining after a September quarter of takeover costs and exploration spending. The company says it needs new funding while a board-control fight threatens to add further uncertainty.
Maxwell Dee
Maxwell Dee
30 Oct 2026
FortifAI has launched the production-ready version of its NOL8 AI Data Plane ahead of schedule, opening the door to paid enterprise proof-of-value engagements. The ASX-listed technology company ended September with A$17.3 million in cash and no debt, but still needs to convert technical validation into contracts and revenue.
Sophie Babbage
Sophie Babbage
30 Oct 2026
Superior Resources has expanded its Queensland exploration portfolio and advanced the Steam Engine gold project, but its annual report carries a material uncertainty over going concern. The company ended June with $1.31 million in cash after a $2 million placement and says further funding will be needed to continue exploration and development.
Maxwell Dee
Maxwell Dee
30 Oct 2026
Scorpion Minerals has strengthened the development case for its Old Prospect gold deposit, with a new open-pit optimisation identifying 16,159 ounces at a A$6,000 per ounce gold price. The project now has a proposed processing pathway and a mining lease application in the Right to Negotiate stage, but funding remains limited as drilling and studies ramp up.
Maxwell Dee
Maxwell Dee
30 Oct 2026
Marmota’s 2026 annual report charts a rapid expansion from a single gold focus to a multi-asset exploration portfolio, led by more than 2km of high-grade Greenewood and Mainwood mineralisation. The company finished the year with A$14.36 million in cash after a A$15 million placement, but remains firmly in the exploration stage.
Victor Sage
Victor Sage
30 Oct 2026
Alvo Minerals has expanded its Bluebush heavy rare earth project in Brazil, with new ground, encouraging clay intercepts and Florence drilling advancing toward a maiden resource. But quarter-end cash of A$227,000 covered only 0.28 quarters of reported outgoings before a subsequent A$1 million placement and option exercises.
Maxwell Dee
Maxwell Dee
30 Oct 2026
Axtec has moved several proptech partnerships towards commercial rollout, but its September quarter cash position leaves just 0.58 quarters of estimated funding. The company is pursuing strategic investment and expects an R&D rebate, neither of which has been secured in the filing.
Victor Sage
Victor Sage
30 Oct 2026
Chariot Resources has moved its Nigerian lithium strategy forward with licence approvals, geological mapping and a proposed partner-funded drilling and offtake program. But with A$600,000 in cash, A$3.19 million of borrowings and an estimated 0.75 quarters of funding, the next phase depends on securing more capital.
Maxwell Dee
Maxwell Dee
30 Oct 2026
Coppermoly ended the September quarter with $92,000 in cash and estimated funding for just 0.38 quarters of relevant outgoings. The mineral explorer is cutting costs, narrowing its Queensland portfolio and assessing potential funding and acquisition options after its managing director’s departure.
Maxwell Dee
Maxwell Dee
30 Oct 2026
Cadoux Limited (ASX:CCM) has strengthened the technical case for its high-purity alumina and rare earths portfolio, including battery qualification and new Danube mineralisation beyond its previous exploration envelope. The progress comes with a thinner cash buffer, no listed financing facilities and several commercial milestones still ahead.
Victor Sage
Victor Sage
30 Oct 2026
Gateway Mining has expanded its Cowza discovery to approximately 4.5 kilometres of mineralised strike and confirmed high-grade gold in fresh rock with a 41-metre intercept at 2.0g/t. A $45 million placement and $8.23 million securities sale left the explorer with $52.84 million in cash at quarter-end to accelerate drilling across Yandal.
Maxwell Dee
Maxwell Dee
30 Oct 2026
Adherium delivered a fifth consecutive quarterly record for remote patient monitoring revenue, but ended September with only A$120,000 in cash after a A$3.499 million operating outflow. Post-quarter loans and an AstraZeneca milestone payment have improved near-term liquidity, although further funding remains central to the company’s plans.
Victor Sage
Victor Sage
30 Oct 2026

Browse the archive

Full archive